Abstract
Obesity, now a worldwide epidemic, causes myriad medical problems. One of the most significant obesity-related problems is the well-recognized relationship between obesity and various malignancies, including pancreatic cancer. Pancreatic cancer is a devastating disease – the annual death rate nearly approximates its incidence. While surgical extirpation provides the best chance at long term survival, systemic therapy is largely ineffective: even those patients undergoing successful operative resection have only approximately 20% 5-year survival. These poor outcomes are largely a consequence of poor understanding of tumor biology. Clearly, identification of novel treatment strategies is of paramount importance; investigation of pancreatic cancer biology from the novel aspect of obesity offers the potential to identify unique therapeutic targets. This manuscript reviews the epidemiology, clinical findings, and putative basic science mechanisms underlying obesity-related pancreatic cancer.
Keywords: Pancreatic cancer, obesity, adipokines, tumor immunology, adiponectin, leptin, B-lymphocytes
Anti-Cancer Agents in Medicinal Chemistry
Title: Pancreatic Cancer in Obesity: Epidemiology, Clinical Observations, and Basic Mechanisms
Volume: 11 Issue: 5
Author(s): Nicholas J. Zyromski and Patrick B. White
Affiliation:
Keywords: Pancreatic cancer, obesity, adipokines, tumor immunology, adiponectin, leptin, B-lymphocytes
Abstract: Obesity, now a worldwide epidemic, causes myriad medical problems. One of the most significant obesity-related problems is the well-recognized relationship between obesity and various malignancies, including pancreatic cancer. Pancreatic cancer is a devastating disease – the annual death rate nearly approximates its incidence. While surgical extirpation provides the best chance at long term survival, systemic therapy is largely ineffective: even those patients undergoing successful operative resection have only approximately 20% 5-year survival. These poor outcomes are largely a consequence of poor understanding of tumor biology. Clearly, identification of novel treatment strategies is of paramount importance; investigation of pancreatic cancer biology from the novel aspect of obesity offers the potential to identify unique therapeutic targets. This manuscript reviews the epidemiology, clinical findings, and putative basic science mechanisms underlying obesity-related pancreatic cancer.
Export Options
About this article
Cite this article as:
J. Zyromski Nicholas and B. White Patrick, Pancreatic Cancer in Obesity: Epidemiology, Clinical Observations, and Basic Mechanisms, Anti-Cancer Agents in Medicinal Chemistry 2011; 11 (5) . https://dx.doi.org/10.2174/187152011795677445
DOI https://dx.doi.org/10.2174/187152011795677445 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Evolution of Bronchoscopy
Current Respiratory Medicine Reviews Relationship Between Drugs and Functional Activity of Various Mammalian P-Glycoproteins (ABCB1)
Mini-Reviews in Medicinal Chemistry New Strategies Against Prostate Cancer – Pt(II)-Based Chemotherapy
Current Medicinal Chemistry Cancer and Aids: New Trends in Drug Design and Chemotherapy
Current Computer-Aided Drug Design Valproic Acid Metabolism and its Consequences on Sexual Functions
Current Drug Metabolism Role of Toxicogenomics in the Development of Safe, Efficacious and Novel Anti-microbial Therapies.
Infectious Disorders - Drug Targets Metal Ions and Metal Complexes in Alzheimer’s Disease
Current Pharmaceutical Design The Development of Antimicrobial Peptides as New Antibacterial Drugs
Current Protein & Peptide Science Serotonin and Cancer: What Is the Link?
Current Molecular Medicine Synthesis of Pyridine and Spiropyridine Derivatives Derived from 2-aminoprop- 1-ene-1,1,3-tricarbonitrile Together with their c-Met Kinase and Antiproliferative Evaluations
Anti-Cancer Agents in Medicinal Chemistry Signaling Through Rho GTPase Pathway as Viable Drug Target
Current Medicinal Chemistry Targeting Ion Channels in Leukemias: A New Challenge for Treatment
Current Medicinal Chemistry Cell-free DNA: Characteristics, Detection and its Applications in Myocardial Infarction
Current Pharmaceutical Design Genetics of Bladder Malignant Tumors in Childhood
Current Genomics Artificial Intelligence for Epigenetics: Towards Personalized Medicine
Current Medicinal Chemistry Down-regulating Glypican-3 Expression: Molecular-targeted Therapy for Hepatocellular Carcinoma
Mini-Reviews in Medicinal Chemistry Recent Advances in Synthesis of PAR Ligands as Therapeutic Strategy for Inflammatory Diseases
Mini-Reviews in Medicinal Chemistry Antidiabetic Potential of Fabaceae Family: An Overview
Current Nutrition & Food Science An Overview on Fibroblast Growth Factors: Structural, Functional and Therapeutic Implications
Current Proteomics C/EBPα Regulates FOXC1 to Modulate Tumor Growth by Interacting with PPARγ in Hepatocellular Carcinoma
Current Cancer Drug Targets